Swedbank’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120M | Buy |
228,297
+4,509
| +2% | +$2.37M | 0.13% | 125 |
|
|
2025
Q1 | $142M | Buy |
223,788
+45,297
| +25% | +$28.7M | 0.19% | 104 |
|
|
2024
Q4 | $127M | Buy |
178,491
+29,128
| +20% | +$20.7M | 0.16% | 111 |
|
|
2024
Q3 | $157M | Buy |
149,363
+13,705
| +10% | +$14.4M | 0.2% | 102 |
|
|
2024
Q2 | $143M | Buy |
+135,658
| New | +$143M | 0.19% | 96 |
|
|
2024
Q1 | – | Sell |
-103,943
| Closed | -$91.3M | – | 685 |
|
|
2023
Q4 | $91.3M | Buy |
103,943
+57,238
| +123% | +$50.3M | 0.15% | 119 |
|
|
2023
Q3 | $38.4M | Buy |
46,705
+2,715
| +6% | +$2.23M | 0.07% | 198 |
|
|
2023
Q2 | $31.6M | Buy |
43,990
+1,227
| +3% | +$882K | 0.05% | 239 |
|
|
2023
Q1 | $35.1M | Buy |
42,763
+1,976
| +5% | +$1.62M | 0.07% | 216 |
|
|
2022
Q4 | $29.4M | Buy |
40,787
+2,555
| +7% | +$1.84M | 0.06% | 244 |
|
|
2022
Q3 | $26.3M | Buy |
38,232
+2,002
| +6% | +$1.38M | 0.06% | 248 |
|
|
2022
Q2 | $21.4M | Buy |
36,230
+1,281
| +4% | +$757K | 0.05% | 283 |
|
|
2022
Q1 | $24.4M | Buy |
34,949
+397
| +1% | +$277K | 0.05% | 295 |
|
|
2021
Q4 | $22.2M | Sell |
34,552
-6,030
| -15% | -$3.87M | 0.04% | 326 |
|
|
2021
Q3 | $24.6M | Buy |
40,582
+174
| +0.4% | +$105K | 0.05% | 301 |
|
|
2021
Q2 | $22.6M | Hold |
40,408
| – | – | 0.04% | 318 |
|
|
2021
Q1 | $19.1M | Buy |
+40,408
| New | +$19.1M | 0.04% | 342 |
|